“A new type of vaccine developed by researchers at the University of Chicago’s Pritzker School of Molecular Engineering (PME) has shown in the lab setting that it can completely reverse autoimmune diseases like multiple sclerosis and type 1 diabetes — all without shutting down the rest of the immune system.”
From University of Chicago.
“The US Food and Drug Administration has approved the world’s first vaccine for chikungunya, which it sees as an ’emerging global health threat.’ The mosquito-borne disease causes fever and joint pains and can be fatal to newborns.
The FDA’s approval is expected to speed up the vaccine’s global rollout. This year, about 440,000 chikungunya cases, including 350 deaths, have been reported as of September.”
From BBC.
“Scientists in Brazil have announced the development of an innovative new vaccine to treat addiction to cocaine and its powerful derivative, crack.
Dubbed ‘Calixcoca,’ the treatment, which has shown promising results in trials on animals, triggers an immune response that blocks cocaine and crack from reaching the brain. In simple terms, the vaccine would work by preventing addicts from getting high from the drug.”
From Euronews.
“In a major analysis in Africa, the first vaccine approved to fight malaria cut deaths among young children by 13% over nearly 4 years, the World Health Organization (WHO) reported last week. The huge evaluation of a pilot rollout of the vaccine, called RTS,S or Mosquirix and made by GlaxoSmithKline, also showed a 22% reduction in severe malaria in kids young enough to receive a three-shot series.”
From Science.
“UNICEF today announced an agreement to secure supply of the world’s second malaria vaccine, R21/Matrix-M. The deal is a major milestone towards meeting the high demand for doses of new vaccines against malaria – a disease which still kills one child under five every minute.”
From UNICEF.
